We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nitric Oxide Holds Benefits for Intensive Care Patients

By HospiMedica International staff writers
Posted on 16 Oct 2011
A new study suggests that the body's production of nitric oxide (NO) in response to low oxygen levels could improve the recovery of critically ill patients in intensive care.

Researchers at University College London (UCL; United Kingdom) and the University of Warwick (United Kingdom) conducted a study that involved blood samples and results collected from 198 trekkers and 24 climbers (including doctors and scientists) that participated in the 2007 Caudwell Xtreme Everest (CXE) expedition. More...
Using an integrated biochemical/whole-body physiology approach, the researchers were able to show that nitrite and nitrate--plasma biomarkers of NO production--and activity (cGMP) are elevated on acclimatization to high altitude, while S-nitrosothiols are initially consumed, suggesting multiple NOs contribute to improve hypoxia tolerance by enhancing NO availability.

The results suggest that NO is an integral part of the human physiological response to hypoxia, a finding that may be of relevance not only to healthy subjects exposed to high altitude, but also to patients in whom oxygen availability is limited by diseases affecting the heart, lung, or vasculature. The results also show that NO production and activity are elevated in people who live at near sea-level altitudes that ascend to altitude, leading to changes in blood flow in the smallest blood vessels. The results are also consistent with earlier data from residents of the Tibetan plateau, showing their normal NO levels to be much elevated compared to people living near sea-level. The study was published in the October 6, 2011, issue of Scientific Reports.

“By taking blood samples from hypoxic, but otherwise healthy, individuals we have been able to show that the body's natural response to low oxygen availability is to increase the production of nitric oxide,” said joint lead author Denny Levett, MD, of the UCL Center for Altitude, Space, and Extreme Environment Medicine. “Thus, elevated NO occurs not just in those who live at high altitudes permanently, but also in lowlanders who are trying to adapt to high altitude conditions.”

NO is a ubiquitous signaling molecule produced through the metabolism of L-arginine by nitric oxide synthases (NOS). Its formation is crucial for the control of blood pressure, blood flow, and other vital bodily functions; amongst these, it is an important antioxidant, and a regulator of intermediary metabolism and cellular energy production by mitochondria.

Related Links:

University College London
University of Warwick


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.